"When you have cancer, you want the best physicians fighting for you. That’s why the physicians of Thompson Oncology Group are board-certified and fellowship-trained with only one mission: to eradicate your cancer. Our oncologists use proven drug-based treatments and the latest clinical trial medicines to ensure you receive the most effective treatment."

During the past decade, Thompson Oncology Group-Oak Ridge conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thompson Oncology Group-Oak Ridge" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NRG Oncology" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thompson Oncology Group-Oak Ridge" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Thompson Oncology Group-Oak Ridge" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Colon Adenocarcinoma" (2 trials), "Recurrent Melanoma" (2 trials) and "Recurrent Ovarian Carcinoma" (2 trials). Many other conditions were trialed in "Thompson Oncology Group-Oak Ridge" in a lesser frequency.

Most popular intervention types in "Thompson Oncology Group-Oak Ridge" are "Drug" (15 trials), "Other" (14 trials), "Biological" (10 trials), "Procedure" (9 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (7 trials), "Quality-of-Life Assessment" (7 trials), "Laboratory Biomarker Analysis" (6 trials), "Nivolumab" (6 trials) and "Biospecimen Collection" (5 trials). Other intervention names were less common.

The vast majority of trials in "Thompson Oncology Group-Oak Ridge" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Thompson Oncology Group-Oak Ridge". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Thompson Oncology Group-Oak Ridge, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Thompson Oncology Group-Oak Ridge, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".